Chronic obstructive pulmonary disease : management of chronic obstructive pulmonary disease in adults in primary and secondary care : update guideline / National Clinical Guideline Centre for Acute and Chronic Conditions (Great Britain).

Format:

Book

Author/Creator:

National Clinical Guideline Centre for Acute and Chronic Conditions (Great Britain), author, issuing body.

Series:

National clinical practice guideline ; Number 101.

National clinical practice guideline ; Number 101

Language:

English

Subjects (All):

Lungs--Diseases, Obstructive.

Lungs.

Physical Description:

1 online resource.

Place of Publication:

London : National Clinical Guideline Centre-Acute and Chronic Conditions at the Royal College of Physicians, 2010.

Summary:

This guideline offers best practice advice on the identification and care of patients with chronic obstructive pulmonary disease (COPD). It aims to define the symptoms, signs and investigations required to establish a diagnosis of COPD. It also aims to define the factors that are necessary to assess its severity, provide prognostic information and guide best management. It gives guidance on the pharmacological and non-pharmacological treatment of patients with stable COPD, and on the management of exacerbations. The interface with surgery and intensive therapy units (ITU) are also discussed.

Contents:

Acknowledgements for the original guideline

Acknowledgements for the update guideline

Development Group Membership for the original guideline

NEW 2010 Update guideline development group members

Preface to original guideline

Preface to NEW 2010 update guideline

1. Introduction

1.1. Definition of chronic obstructive pulmonary disease

1.2. Clinical context

1.3. Original guideline aims

1.4. Patient choice

1.5. Underlying guideline principles

1.6. Structure of the original guideline

1.7. Updating a NICE guideline

1.8. Update aim

1.9. Scope

1.10. Audience

1.11. Involvement of people with COPD

1.12. Guideline limitations

1.13. Other work relevant to the guideline

2. Methodology

2.1. The process of guideline development (for a partial update)

2.2. Re-run evidence

2.3. Disclaimer

2.4. Funding

3. Hierarchy of evidence and grading of recommendations

4. Glossary of terms

5. Summary of key priorities for implementation, algorithms and audit criteria

5.1. Key priorities for implementation

5.2. Algorithms

5.3. Suggested audit criteria for implementation

6. Diagnosing COPD

6.1. Introduction

6.2. Symptoms

6.3. Signs

6.4. Spirometry

6.5. Differential diagnosis

6.6. Further investigations

6.7. Reversibility testing

6.8. Assessment of severity and prognostic factors

6.9. Assessment and classification of severity of airflow obstruction

6.10. Identification of early disease

6.11. Referral for specialist advice

7. Managing stable COPD

7.1. Introduction

7.2. Smoking cessation

7.3. Inhaled therapy

7.4. Oral therapy

7.5. Combined oral and inhaled therapy

7.6. Oxygen

7.7. Non-invasive ventilation

7.8. Management of pulmonary hypertension and cor pulmonale

7.9. Pulmonary rehabilitation

7.10. Vaccination and anti-viral therapy

7.11. Lung surgery

7.12. Alpha-1 antitrypsin replacement therapy

7.13. Multidisciplinary management

7.14. Fitness for general surgery

7.15. Follow-up of patients with COPD

8. Management of exacerbations of COPD

8.1. Introduction

8.2. Definition of an exacerbation

8.3. Consequences of having an exacerbation

8.4. Causes of an exacerbation

8.5. Symptoms of an exacerbation

8.6. Differential diagnosis of an exacerbation

8.7. Assessment of the severity of an exacerbation

8.8. Assessment of need for hospital treatment

8.9. Investigation of an exacerbation

8.10. Hospital-at-home and assisted-discharge schemes

8.11. Pharmacological management

8.12. Oxygen therapy during exacerbations of COPD

8.13. Non-invasive ventilation (NIV) and COPD exacerbations

8.14. Invasive ventilation and intensive care

8.15. Respiratory physiotherapy and exacerbations

8.16. Monitoring recovery from an exacerbation

8.17. Discharge planning

9. Audit criteria

Sentinel events audit

10. Areas for Future Research

10.1. General Points

10.2. Specific points

10.3. NEW 2010 UPDATE Future research recommendations

Appendix A. Details of questions and literature searches

Appendix B. Cost effectiveness of opportunistic case finding in primary care

Appendix C. Educational packages

Appendix D. Economic costs of COPD to the NHS

Appendix E. Searching for health economics evidence

Appendix F. Evidence tables

Appendices for NEW 2010 update

Appendix G. NEW 2010 update Scope

Appendix H. NEW 2010 update PICO questions

Appendix I. NEW 2010 update research protocols

Appendix J. NEW 2010 update literature searches

Appendix K. NEW 2010 deleted sections from original guideline

Appendix L. NEW 2010 update criteria for selecting high-priority research recommendations

Appendix M. NEW 2010 update cost effectiveness modelling

Appendix N. NEW 2010 COPD update GDG declarations of interest register

Appendix O. NEW 2010 COPD update forest plots

27 Reference List.

Notes:

Description based on publisher supplied metadata and other sources.